Loading company…
Sabai Global provides regulatory review and biosafety consulting for clinical and pharmaceutical research.
Sabai Global provides institutional biosafety committee risk reviews, submission support, IRB reviews, and on-call biosafety services. It serves pharmaceutical sponsors, contract research organizations, academic health systems, clinical research networks, and vendors. Based in Missouri, US, the company was founded in 2018. Thompson Street Capital Partners invested in it in 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in